vs
亚什兰(ASH)与Axos Financial, Inc.(AX)财务数据对比。点击上方公司名可切换其他公司
亚什兰的季度营收约是Axos Financial, Inc.的1.0倍($386.0M vs $385.1M),Axos Financial, Inc.净利率更高(33.3% vs -3.1%,领先36.5%),Axos Financial, Inc.同比增速更快(25.1% vs -4.7%),亚什兰自由现金流更多($111.0M vs $85.4M),过去两年Axos Financial, Inc.的营收复合增速更高(14.3% vs -18.1%)
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业,1924年始创于肯塔基州亚什兰市,最初以炼油业务起家,1994年迁至现总部。公司拥有多个业务板块,覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域,2017年之前曾是胜牌润滑油的主要生产商。
Axos Financial是总部位于美国内华达州拉斯维加斯的银行控股公司,旗下拥有直销银行Axos Bank,同时提供注册投资顾问服务及电子交易平台,深耕数字化金融赛道,可为用户提供多元便捷的金融服务解决方案。
ASH vs AX — 直观对比
营收规模更大
ASH
是对方的1.0倍
$385.1M
营收增速更快
AX
高出29.8%
-4.7%
净利率更高
AX
高出36.5%
-3.1%
自由现金流更多
ASH
多$25.6M
$85.4M
两年增速更快
AX
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $386.0M | $385.1M |
| 净利润 | $-12.0M | $128.4M |
| 毛利率 | 27.2% | — |
| 营业利润率 | -1.6% | 45.6% |
| 净利率 | -3.1% | 33.3% |
| 营收同比 | -4.7% | 25.1% |
| 净利润同比 | 92.7% | 22.6% |
| 每股收益(稀释后) | $-0.26 | $2.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASH
AX
| Q4 25 | $386.0M | $385.1M | ||
| Q3 25 | $477.0M | $323.4M | ||
| Q2 25 | $463.0M | $321.4M | ||
| Q1 25 | $479.0M | $308.8M | ||
| Q4 24 | $405.0M | $307.9M | ||
| Q3 24 | $521.0M | $320.7M | ||
| Q2 24 | $544.0M | $290.9M | ||
| Q1 24 | $575.0M | $294.8M |
净利润
ASH
AX
| Q4 25 | $-12.0M | $128.4M | ||
| Q3 25 | $31.0M | $112.4M | ||
| Q2 25 | $-742.0M | $110.7M | ||
| Q1 25 | $31.0M | $105.2M | ||
| Q4 24 | $-165.0M | $104.7M | ||
| Q3 24 | $17.0M | $112.3M | ||
| Q2 24 | $6.0M | $104.9M | ||
| Q1 24 | $120.0M | $110.7M |
毛利率
ASH
AX
| Q4 25 | 27.2% | — | ||
| Q3 25 | 33.3% | — | ||
| Q2 25 | 28.5% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 27.4% | — | ||
| Q3 24 | 33.2% | — | ||
| Q2 24 | 34.2% | — | ||
| Q1 24 | 28.0% | — |
营业利润率
ASH
AX
| Q4 25 | -1.6% | 45.6% | ||
| Q3 25 | 12.8% | 46.3% | ||
| Q2 25 | -152.9% | 48.5% | ||
| Q1 25 | 10.6% | 47.9% | ||
| Q4 24 | -44.2% | 48.8% | ||
| Q3 24 | 6.1% | 49.6% | ||
| Q2 24 | -11.2% | 49.6% | ||
| Q1 24 | 3.7% | 52.8% |
净利率
ASH
AX
| Q4 25 | -3.1% | 33.3% | ||
| Q3 25 | 6.5% | 34.7% | ||
| Q2 25 | -160.3% | 34.4% | ||
| Q1 25 | 6.5% | 34.1% | ||
| Q4 24 | -40.7% | 34.0% | ||
| Q3 24 | 3.3% | 35.0% | ||
| Q2 24 | 1.1% | 36.0% | ||
| Q1 24 | 20.9% | 37.6% |
每股收益(稀释后)
ASH
AX
| Q4 25 | $-0.26 | $2.22 | ||
| Q3 25 | $0.83 | $1.94 | ||
| Q2 25 | $-16.21 | $1.89 | ||
| Q1 25 | $0.65 | $1.81 | ||
| Q4 24 | $-3.50 | $1.80 | ||
| Q3 24 | $0.34 | $1.93 | ||
| Q2 24 | $0.12 | $1.75 | ||
| Q1 24 | $2.39 | $1.91 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $1.0B |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $1.9B | $2.9B |
| 总资产 | $4.5B | $28.2B |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势,按日历期对齐
现金及短期投资
ASH
AX
| Q4 25 | $304.0M | $1.0B | ||
| Q3 25 | $215.0M | $2.6B | ||
| Q2 25 | $207.0M | $1.9B | ||
| Q1 25 | $168.0M | $2.0B | ||
| Q4 24 | $219.0M | $2.4B | ||
| Q3 24 | $300.0M | $2.6B | ||
| Q2 24 | $399.0M | $2.0B | ||
| Q1 24 | $439.0M | $2.1B |
总债务
ASH
AX
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | $312.7M | ||
| Q1 25 | $1.3B | $377.4M | ||
| Q4 24 | $1.3B | $358.7M | ||
| Q3 24 | $1.3B | $313.5M | ||
| Q2 24 | $1.3B | $325.7M | ||
| Q1 24 | $1.3B | $330.4M |
股东权益
ASH
AX
| Q4 25 | $1.9B | $2.9B | ||
| Q3 25 | $1.9B | $2.8B | ||
| Q2 25 | $1.9B | $2.7B | ||
| Q1 25 | $2.6B | $2.6B | ||
| Q4 24 | $2.6B | $2.5B | ||
| Q3 24 | $2.9B | $2.4B | ||
| Q2 24 | $3.0B | $2.3B | ||
| Q1 24 | $3.1B | $2.2B |
总资产
ASH
AX
| Q4 25 | $4.5B | $28.2B | ||
| Q3 25 | $4.6B | $27.4B | ||
| Q2 25 | $4.6B | $24.8B | ||
| Q1 25 | $5.2B | $24.0B | ||
| Q4 24 | $5.2B | $23.7B | ||
| Q3 24 | $5.6B | $23.6B | ||
| Q2 24 | $5.7B | $22.9B | ||
| Q1 24 | $5.9B | $22.6B |
负债/权益比
ASH
AX
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.73× | 0.12× | ||
| Q1 25 | 0.52× | 0.14× | ||
| Q4 24 | 0.51× | 0.14× | ||
| Q3 24 | 0.47× | 0.13× | ||
| Q2 24 | 0.45× | 0.14× | ||
| Q1 24 | 0.42× | 0.15× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $125.0M | $104.1M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | $85.4M |
| 自由现金流率自由现金流/营收 | 28.8% | 22.2% |
| 资本支出强度资本支出/营收 | 3.6% | 4.9% |
| 现金转化率经营现金流/净利润 | — | 0.81× |
| 过去12个月自由现金流最近4个季度 | $200.0M | $695.9M |
8季度趋势,按日历期对齐
经营现金流
ASH
AX
| Q4 25 | $125.0M | $104.1M | ||
| Q3 25 | $40.0M | $118.4M | ||
| Q2 25 | $115.0M | $490.3M | ||
| Q1 25 | $9.0M | $73.7M | ||
| Q4 24 | $-30.0M | $162.5M | ||
| Q3 24 | $80.0M | $70.8M | ||
| Q2 24 | $127.0M | $305.5M | ||
| Q1 24 | $54.0M | $115.8M |
自由现金流
ASH
AX
| Q4 25 | $111.0M | $85.4M | ||
| Q3 25 | $6.0M | $109.3M | ||
| Q2 25 | $95.0M | $436.1M | ||
| Q1 25 | $-12.0M | $65.1M | ||
| Q4 24 | $-53.0M | $156.4M | ||
| Q3 24 | $42.0M | $53.0M | ||
| Q2 24 | $98.0M | $269.5M | ||
| Q1 24 | $20.0M | $107.3M |
自由现金流率
ASH
AX
| Q4 25 | 28.8% | 22.2% | ||
| Q3 25 | 1.3% | 33.8% | ||
| Q2 25 | 20.5% | 135.7% | ||
| Q1 25 | -2.5% | 21.1% | ||
| Q4 24 | -13.1% | 50.8% | ||
| Q3 24 | 8.1% | 16.5% | ||
| Q2 24 | 18.0% | 92.6% | ||
| Q1 24 | 3.5% | 36.4% |
资本支出强度
ASH
AX
| Q4 25 | 3.6% | 4.9% | ||
| Q3 25 | 7.1% | 2.8% | ||
| Q2 25 | 4.3% | 16.9% | ||
| Q1 25 | 4.4% | 2.8% | ||
| Q4 24 | 5.7% | 2.0% | ||
| Q3 24 | 7.3% | 5.5% | ||
| Q2 24 | 5.3% | 12.4% | ||
| Q1 24 | 5.9% | 2.9% |
现金转化率
ASH
AX
| Q4 25 | — | 0.81× | ||
| Q3 25 | 1.29× | 1.05× | ||
| Q2 25 | — | 4.43× | ||
| Q1 25 | 0.29× | 0.70× | ||
| Q4 24 | — | 1.55× | ||
| Q3 24 | 4.71× | 0.63× | ||
| Q2 24 | 21.17× | 2.91× | ||
| Q1 24 | 0.45× | 1.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
AX
暂无分部数据